Companies / BOC Sciences / Matuzumab
BOC Sciences

Matuzumab | BOC Sciences

Matuzumab is a humanized monoclonal antibody that binds to the epidermal growth factor receptor (EGFR). EGFR existing on the surface of normal and tumor cells binds to EGF (epidermal growth factor) and other EGF family growth factors, which leads to the activation of EGFR. Matuzumab is used as an anti-cancer drug.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.